申请人:Hoffmann-La Roche Inc.
公开号:US06200989B1
公开(公告)日:2001-03-13
Compounds of the formula
wherein R,R′, A,B,T and x have the meaning given in the specification possess uPA (urokinase-type plasminogen activator) antagonist activity and can be employed as antitumor and/or antimetastatic agents.
具有以下给定含义的R,R',A,B,T和x的化合物具有uPA(尿激酶型纤溶酶原激活剂)拮抗活性,并可用作抗肿瘤和/或抗转移药物。